Can a hemodialysis session be performed on a patient with Chronic Kidney Disease (CKD) who has tachycardia (elevated pulse rate) and normal blood pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Hemodialysis Be Performed with Pulse Rate 138 bpm and BP 120/80?

Yes, hemodialysis can be performed in this patient, but the tachycardia requires immediate investigation and continuous cardiac monitoring during the session, as the elevated heart rate (138 bpm) represents a significant mortality risk factor even though the blood pressure is acceptable. 1

Immediate Pre-Dialysis Assessment Required

Before proceeding with dialysis, you must:

  • Obtain a 12-lead ECG immediately to identify the underlying rhythm (atrial fibrillation, sinus tachycardia, ventricular tachycardia, or other arrhythmia), as all dialysis patients with new or unexplained tachycardia require ECG evaluation 1
  • Check electrolytes urgently (potassium, magnesium, calcium) as these are the primary triggers of life-threatening dysrhythmias in CKD patients, with hyperkalemia accounting for a substantial proportion of sudden cardiac deaths 1
  • Assess volume status clinically to determine if the tachycardia represents compensatory response to volume overload or other hemodynamic stress 2
  • Review medications for QT-prolonging agents or recent changes in beta-blockers, as dialysis can remove beta-blockers leading to rebound tachycardia 1

Blood Pressure Considerations

The BP of 120/80 mmHg is acceptable for proceeding with dialysis:

  • This BP falls within safe parameters for hemodialysis initiation, as current guidelines recommend treating CKD patients when office BP is ≥140/90 mmHg, and targeting systolic BP to 130-139 mmHg range 2
  • Pre-dialysis BP of 120/80 mmHg does not contraindicate dialysis, though post-dialytic drops in systolic BP of up to 30 mmHg are associated with higher survival, while greater decreases or any increase in systolic BP are related to increased mortality 2
  • Standing BP measurement is mandatory before proceeding, as orthostatic hypotension may be masked by the sitting measurement and could predict intradialytic hemodynamic instability 3

The Tachycardia Problem: Why It Matters

Pre-hemodialysis pulse rate ≥80 bpm carries significantly increased 1-year mortality risk, making this patient's heart rate of 138 bpm particularly concerning 1, 4:

  • Compromised myocardium from underlying coronary artery disease cannot tolerate the combined stress of rapid ultrafiltration and elevated heart rate, increasing risk of myocardial ischemia and arrhythmias 1
  • Left ventricular hypertrophy (present in 80% of dialysis patients) further impairs diastolic filling when heart rate is elevated, contributing to hemodynamic instability 1
  • Dynamic electrolyte fluctuations during dialysis create a dysrhythmogenic state that persists for 4-5 hours after dialysis, particularly dangerous in patients with underlying structural cardiac abnormalities 1
  • Potentially life-threatening ventricular dysrhythmias occur in 29% of patients during 24-hour monitoring that includes the dialysis period, with atrial dysrhythmias in 10% and ventricular dysrhythmias in 76% of maintenance hemodialysis patients 1

Mandatory Monitoring During This Session

Continuous ECG monitoring is required throughout this dialysis session given the tachycardia, as recommended for hospitalized hemodialysis patients with severe electrolyte abnormalities, QT-prolonging medications, or known structural heart disease 1, 4:

  • Cardiac arrest rate during hemodialysis is 7 events per 100,000 dialysis sessions, with 62% presenting as ventricular fibrillation/ventricular tachycardia, highlighting the importance of continuous monitoring in high-risk patients 1, 4
  • Blood pressure measurements should be increased to every 15-30 minutes when tachycardia is present, rather than the standard hourly measurements 4, 3
  • Ensure automatic external defibrillator availability, as it should be present in all outpatient hemodialysis clinics 4

Dialysis Prescription Modifications

Consider these adjustments to improve hemodynamic stability:

  • Use cooler dialysate temperature (0.5°C below core body temperature) to improve vascular stability and reduce circulatory stress, as this approach reduces mean arterial pressure extrema point frequencies and may protect against dialysis-induced brain injury 2, 1
  • Extend treatment time beyond the standard 3 hours if the patient has high interdialytic weight gain or requires aggressive ultrafiltration, as longer treatment times improve hemodynamic stability during HD 2
  • Reduce ultrafiltration rate if possible to minimize hemodynamic stress, as the safety and tolerability of HD is dictated in part by the ultrafiltration rate 2
  • Adjust dialysate composition to minimize electrolyte fluctuations rather than using IV supplementation, particularly for potassium and magnesium 1

Electrolyte Management Strategy

Maintain serum potassium between 3.5-4.5 mmol/L and magnesium above threshold levels to minimize risk of arrhythmias 1:

  • Do not treat hypokalemia or hypocalcemia without checking and correcting magnesium first, as these will be refractory to replacement 1
  • Never give IV magnesium supplementation during dialysis, as this can cause dangerous fluctuations 1
  • Monitor electrolytes during dialysis and for 4-5 hours post-dialysis, as the dysrhythmogenic state persists well after the session ends 1

Common Pitfalls to Avoid

  • Do not proceed without identifying the underlying rhythm, as ventricular tachycardia requires immediate cardioversion if hemodynamically unstable 1
  • Do not assume the tachycardia will resolve with fluid removal alone, as multiple mechanisms beyond volume overload can cause elevated heart rate in dialysis patients 1
  • Do not use sotalol if the patient has systolic dysfunction or heart failure, as it has been associated with pro-arrhythmia in ESRD patients 1
  • Do not defer the dialysis session if the patient is volume overloaded, as the risks of uremia and volume overload may outweigh the tachycardia risk, but proceed with enhanced monitoring 2

Post-Dialysis Management

The patient requires close follow-up after this session:

  • Repeat ECG post-dialysis to assess for rhythm changes and QTc interval 4
  • Recheck electrolytes 4-5 hours post-dialysis, as arrhythmias often occur during this period due to ongoing electrolyte fluctuations 1
  • Consider cardiology consultation if tachycardia persists or if ventricular arrhythmias are identified, as device therapy or antiarrhythmic medications may be indicated 1
  • Evaluate for underlying causes including infection, anemia, thyroid dysfunction, or cardiac ischemia that may be driving the tachycardia 1

References

Guideline

Tachycardia in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Blood Pressure Monitoring Frequency During Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Monitoring Intervals in Hemodialysis Centers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the appropriate management for a hemodialysis patient with pain in the mastoid to external auditory meatus (EAM) and temporal region of the head?
What are suitable antihypertensive (anti-hypertensive) options for patients undergoing dialysis (renal replacement therapy)?
What are the preferred antihypertensive agents for patients with End-Stage Renal Disease (ESRD) on dialysis?
What are the recommended antihypertensives for patients undergoing hemodialysis?
What is the most likely cause of low arterial pressure in a 63-year-old female patient with chronic kidney disease (CKD) secondary to hypertension, undergoing hemodialysis?
Can a patient with end-stage renal disease (ESRD) on dialysis, presenting with tachycardia and normal blood pressure, be treated?
What is an ECG (electrocardiogram) test?
What is the management approach for a patient with suspected aortic dissection, particularly those with a history of hypertension, atherosclerosis, or connective tissue disorders?
What is the difference in presentation and management of cardiomyopathy in patients with a history of illicit drug use versus those with hypertensive pathologic hypertrophic cardiomyopathy?
What are the preoperative medical management guidelines for a patient with comorbidities such as diabetes, hypertension, and cardiovascular disease undergoing pancreatectomy?
What are the diagnostic requirements for cerebral contusion in a patient with symptoms like headache, confusion, and seizures, considering age and medical history?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.